申请人:Brown Alan Daniel
公开号:US20130109708A1
公开(公告)日:2013-05-02
The invention relates to sulfonamide derivatives, to their use in medicine, to 5 compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I):10 X NH O S O O R1 R2 R5 R4 R3 Het1 (I) or a pharmaceutically acceptable salt thereof, wherein X, Het1, R1, R2, R3, R4 and R5 are as defined in the description. 15 Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
本发明涉及磺酰胺衍生物,其在医药上的应用,包含它们的组合物,它们的制备过程以及用于此类过程的中间体。更具体地,本发明涉及一种新的磺酰胺Nav1.7抑制剂,其化学式为(I):其中X、Het1、R1、R2、R3、R4和R5如描述中所定义,或其药学上可接受的盐。Nav1.7抑制剂在治疗广泛的疾病,特别是疼痛方面具有潜在的用途。